Navigation Links
STAAR Surgical Reports 19% Revenue Growth Second Quarter
Date:8/2/2011

0;In our top 10 targeted markets the Visian ICL grew by 48% with six of ten markets growing more than 48%."

"The gross profit margin in the quarter of 66.8% represents a 320 basis point improvement over the second quarter last year and reflects a stronger mix toward higher margin ICL and IOL sales," continued Mr. Caldwell. "I want to thank our employees at STAAR as we challenged them with some stretch objectives and they have responded with a terrific quarter and first half of 2011.  With $13.1 million of cash at the end of the quarter combined with generating cash from operations, we feel very comfortable we can fund current growth plans from our operating cash flow."

"With the regulatory approvals received during the first half of the year and positive momentum, we are poised for continued strong growth during the second half of 2011.  We are on track with our plans to launch four new products in the second half of the year in countries where we have received approvals.  The new Visian ICL with the CentraFLOW™ proprietary technology is currently in limited marketing release and will be fully launched to the European markets at the ESCRS meeting in September.  The CentraFLOW technology utilizes the KS-AquaPORT™ to restore the natural flow within the eye.  This allows for the elimination of a step which typically requires an additional procedure and visit to the surgeon's office.  We believe this will have a significant impact on  surgeon use and adoption of the Visian ICL."

"Our successful execution has bolstered our confidence in the outlook, and as a result we are raising three of four key metric targets for fiscal 2011.  We continue to expect double-digit growth in revenue, but have increased our target for ICL sales growth from 25% to 30%.  We expect continued expansion of our gross margin and now anticipate it will reach 66.5% for the full year.  Finally, we believe that we will
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000
2. STAAR Surgicals nanoFLEX™ Collamer® IOL Receives CE Mark Approval
3. STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign
4. STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia
5. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
6. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
7. STAAR Surgical Reports Continued Double Digit Core Revenue Growth
8. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
9. STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
10. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
11. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6csvbs/market_assessment ... "Market Assessment of Respiratory Diagnostics in the United ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service provides ... in the United States ... provides detailed analysis of the current and forecasted ...
(Date:5/21/2015)... REDWOOD CITY, Calif. , May 21, 2015  Cardica, ... 20, 2015, new employee Greg Watson , the company,s ... 400,000 shares of the company,s common stock, at a per ... May 20, 2015. The stock option was granted pursuant to ... board of directors in May 2015 under Rule 5653(c)(4) of ...
(Date:5/21/2015)... YORK , 21. Mai 2015 ... DPRX ), ein Unternehmen für ... auf die Entwicklung und Vermarktung von ... konzentriert, kündigte heute eine wissenschaftliche Posterpräsentation ... Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 und ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Cardica Announces New Employment Inducement Grant 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... Direct Factor Xa Inhibitor,Shows a Significant Reduction ... with Enoxaparin with Similarly Low Bleeding,Rates , ... III clinical trial,data presented today at the ... Congress demonstrate that once-daily,rivaroxaban (Xarelto®) achieved superior ...
... Insmed Inc. (NASDAQ:INSM), a ,biopharmaceutical company focused on the ... metabolic diseases with unmet,medical needs, today announced that ... Emerging Growth,Opportunities Conference in New York City. ... Mandarin Oriental Hotel in New,York City, will run ...
Cached Medicine Technology:Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
(Date:5/22/2015)... 22, 2015 According to Berks and ... drug related death, totaling almost 2,500 confirmed drug deaths, as ... state officials, totals 2,489 deaths stemming from legal and illegal ... loses seven people every day to fatal overdoses or other ... out as one of the most rife with drug related ...
(Date:5/22/2015)... 22, 2015 Gateway Building Concepts is ... The services the company specialize in include decks, additions, ... pool houses and much more. , The redesigned ... owner of the company. It includes two geometrical lines ... was thought out to be used with many things ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the opening ... the 16th sweetFrog store located in the Lone Star State. ... the Inc. 500 list of fastest growing companies in 2014. ... Texas for 20 years and love the natural beauty and ... nearby Palestine, sweetFrog locations. “We are really excited about giving ...
(Date:5/22/2015)... Boca Raton, FL (PRWEB) May 22, 2015 ... organization which provides vascular, electrocardiogram (EKG), echocardiogram and ... of David Sempier, a highly respected All American National ... a multi-sport athlete, I find the high level of ... to both the athlete and their athletic trainers, this ...
(Date:5/22/2015)... Ticket Down is a reputable source for ... Eastern Conference Finals Tickets . All seating for the ... the ticket listing. , For the first time in ... of the Eastern Conference. One of the original franchises in ... and downs over the years, but the excitement level for ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... a Year, TAMPA, Fla., Sept. 18 In response ... a two-week coma with a craving for The,Melting Pot, the ... The Melting Pot will fly Jill Finley and her family ... at its annual,meeting. On May 26, Finley,s husband Ryan ...
... Sept. 18 The Raleigh based Sisko,Foundation is once ... tennis event with the third annual "Pick Up the ... outside the RBC Center.,NBC-17,s Kim Genardo will once again ... have the tennis event in the spring and the ...
... ... Hospital, MINNEAPOLIS, Sept. 18 ... released this year,s results from a,comprehensive hospital quality and safety survey of ... in,Rochester and Childrens, Hospitals and Clinics in Minneapolis and St. Paul,were named ...
... Discomfort Associated with Acute, ... Conditions such as Back Pain, SOMERSET, N.J., Sept. ... Drug Administration (FDA) has approved,SOMA(R) (carisoprodol) 250 mg as ... discomfort associated with acute, painful musculoskeletal,conditions, such as backache. ...
... STATION, N.J., Sept. 17 Merck & Co., Inc.,today ... reportedly filed by New,York State and New York City ... the suit as it has defended against the,Medicaid- related ... handful of other,states. Merck carefully studied VIOXX(R) before ...
... Medical practitioners, patients and employers recommend immediate,adoption ... Sept. 17 The Health IT Now!,Coalition, ... former Rep. Nancy,Johnson, held a Capitol Hill ... clear interoperable standards for the rapid deployment ...
Cached Medicine News:Health News:Update on Jill Finley Story, Coma Survivor 2Health News:Sisko Foundation Gears Up to 'Pick Up The Pace Against Breast Cancer' 2Health News:Four Minnesota Hospitals Rate High For Patient Safety and Quality 2Health News:FDA Approves SOMA(R) (carisoprodol) 250 mg 2Health News:FDA Approves SOMA(R) (carisoprodol) 250 mg 3Health News:Merck & Co., Inc. Response to Today's New York Medicaid Suit 2Health News:Merck & Co., Inc. Response to Today's New York Medicaid Suit 3Health News:Health IT Now! Coalition Urges Congress to Pass Health Information Technology Bill This Year 2Health News:Health IT Now! Coalition Urges Congress to Pass Health Information Technology Bill This Year 3
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack....
... IOL is the newest advance in lens ... patient and surgeon in mind. Its unique ... crosslinked with PMMA haptics to provide superb ... performance and biocompatibility. The high memory lathe-cut ...
Raysoft Foldable Intraocular Lens....
BIGBAG Hydrophilic Acrylic Lens for high myopia....
Medicine Products: